Drug Type Small molecule drug |
Synonyms BAY 1753011, BAY-1753011, BAY1753011 |
Target |
Mechanism AVPR antagonists(Vasopressin receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H19Cl2F3N6O3 |
InChIKeyAZXOTZCWQDJCLY-SJCJKPOMSA-N |
CAS Registry1914998-56-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 2 | AT | 29 May 2019 | |
Heart Failure | Phase 2 | BG | 29 May 2019 | |
Heart Failure | Phase 2 | GR | 29 May 2019 | |
Heart Failure | Phase 2 | HU | 29 May 2019 | |
Heart Failure | Phase 2 | IL | 29 May 2019 | |
Heart Failure | Phase 2 | IT | 29 May 2019 | |
Heart Failure | Phase 2 | PL | 29 May 2019 | |
Heart Failure | Phase 2 | PT | 29 May 2019 | |
Heart Failure | Phase 2 | ES | 29 May 2019 |